Micrus Endovascular to Hold 2007 Third Quarter Conference Call on February 12.

SAN JOSE, Calif. -- Micrus Endovascular Corporation (Nasdaq:MEND) today announced that it will release financial results for the quarter ended December 31, 2006 before market open on Monday, February 12, 2007. Micrus' management will host an investment community conference call at 1:00 p.m. Eastern time (10:00 a.m. Pacific time) to discuss those results and answer questions.

Individuals interested in participating in the conference call may do so by dialing [phone] for domestic callers, or [phone] for international callers. Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of the company's Web site at www.micruscorp.com.

A telephone replay will be available for 48 hours following the conclusion of the call by dialing [phone] for domestic callers, or [phone] for international callers, and entering reservation code 7214092.

A webcast replay will be available for 30 days by visiting the Investor Relations section on the Micrus Web site.

About Micrus Endovascular Corporation

Micrus develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms responsible for hemorrhagic stroke, a significant cause of death worldwide. The Micrus product line enables physicians to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system. Micrus' proprietary, three-dimensional microcoils are unique in that they automatically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. Micrus also sells accessory devices and products used in conjunction with its microcoils. For more information, visit www.micruscorp.com.